±È½Ï1-¼×»ùßäßò lupragen nmiÓëÆäËûßäßòÀà´ß»¯¼ÁµÄЧÂÊ
1-¼×»ùßäßò lupragen nmi£º´ß»¯¼Á½ºþÖеġ°ÎäÁÖ¸ßÊÖ¡±
ÔÚ»¯Ñ§·´Ó¦µÄ½ºþÀ´ß»¯¼Á¾ÍÏñÊÇÄǸö×ÜÄÜÒÔÒ»ÕÐÖÆÊ¤¡¢µãʯ³É½ðµÄÎäÁÖ¸ßÊÖ¡£ËüÃÇËä²»Ö±½Ó²ÎÓë·´Ó¦£¬È´ÄÜÈÃÕû¸ö¹ý³Ìʰ빦±¶£¬Ð§ÂÊ·±¶£¬³É±¾½µµÍ¡£¶øÔÚÖÚ¶à´ß»¯¼ÁÖУ¬1-¼×»ùßäßò£¨1-methylimidazole£© ºÍÆäÑÜÉú²úÆ· lupragen nmi ƾ½èÆä³öÉ«µÄ´ß»¯ÐÔÄÜ£¬Öð½¥³ÉΪ»·ÑõÊ÷Ö¬¹Ì»¯¡¢¾Û°±õ¥ºÏ³ÉµÈÁìÓòÖеġ°Ã÷ÐÇÑ¡ÊÖ¡±¡£
½ñÌ죬ÎÒÃǾÍÀ´ÁÄÁÄÕâλ´ß»¯¼Á½çµÄ¡°Ð¡ÏÊÈ⡱¡ª¡ª1-¼×»ùßäßò¼°ÆäÉÌÆ·»¯°æ±¾lupragen nmi£¬¿´¿´ËüÓëÆäËûßäßòÀà´ß»¯¼ÁÏà±È£¬µ½µ×ÓкιýÈËÖ®´¦¡£
Ò»¡¢´Ó½á¹¹ËµÆð£º1-¼×»ùßäßòµÄ»ù±¾ÃæÃ²
ßäßòÀ໯ºÏÎïÊÇÎåÔªÔÓ»·¼îÐÔ»¯ºÏÎ¾ßÓÐÁ½¸öµªÔ×Ó£¬ÆäÖÐÒ»¸ö´øÕýµçºÉ£¬ÁíÒ»¸ö¿ÉÒÔÌṩ¹Â¶Ôµç×Ó£¬Òò´ËÔÚ´ß»¯ÁìÓò±íÏÖÓÅÒì¡£1-¼×»ùßäßò¾ÍÊÇÔÚßäßòµÄ1λÉÏÒýÈëÁËÒ»¸ö¼×»ù£¨¨Cch?£©£¬Ê¹µÃ·Ö×ӵļîÐԺͿռäλ×è¶¼ÓÐËù¸Ä±ä¡£
»¯Ñ§½á¹¹¶Ô±È±í£º
| Ãû³Æ | ·Ö×Óʽ | ·Ö×ÓÁ¿ (g/mol) | ÈÛµã (¡ãc) | ·Ðµã (¡ãc) | Íâ¹Û |
|---|---|---|---|---|---|
| ßäßò | c?h?n? | 68.08 | 89 | 257 | °×É«½á¾§ |
| 1-¼×»ùßäßò | c?h?n? | 82.10 | 43¨C45 | 202¨C204 | µ»ÆÉ«ÒºÌå |
| 2-ÒÒ»ù-4-¼×»ùßäßò | c?h??n? | 110.15 | 100¨C102 | 230¨C235 | ¹ÌÌå |
| 2-±½»ùßäßò | c?h?n? | 144.17 | 180¨C182 | 315 | °×É«¹ÌÌå |
| lupragen nmi | c?h?n?¡¤hcl | 118.55 | 180¨C185 | ¡ª¡ª | °×É«·ÛÄ© |
? СÌùÊ¿£ºlupragen nmi ÊÇ1-¼×»ùßäßòµÄÑÎËáÑÎÐÎʽ£¬³£ÓÃÓÚ»·ÑõÊ÷Ö¬ÌåϵÖÐ×÷ΪDZ·üÐ͹̻¯´Ù½ø¼Á¡£
¶þ¡¢1-¼×»ùßäßò vs ÆäËûßäßòÀà´ß»¯¼Á£ºË²ÅÊÇÕæÕýµÄ¡°Ð§ÂÊÖ®Íõ¡±£¿
Òª±È½Ï´ß»¯¼ÁµÄЧÂÊ£¬ÎÒÃǵÿ´¼¸¸ö¹Ø¼üÖ¸±ê£º·´Ó¦»îÐÔ¡¢´¢´æÎȶ¨ÐÔ¡¢ÊÊÓÃζȷ¶Î§¡¢¶¾ÐÔÓë»·±£ÐÔ¡£ÏÂÃæÎÒÃǾʹÓÕ⼸¸ö·½Ãæ³ö·¢£¬°Ñ1-¼×»ùßäßòºÍËüµÄÐֵܽãÃÃÃǺúñÈÒ»±È¡£
1. ·´Ó¦»îÐÔ¶Ô±È
| ´ß»¯¼ÁÃû³Æ | »îÐԵȼ¶£¨??Ô½¸ßԽǿ£© | ÊÊÓ÷´Ó¦ÀàÐÍ | »îÐÔζȷ¶Î§£¨¡æ£© |
|---|---|---|---|
| 1-¼×»ùßäßò | ???? | »·ÑõÊ÷Ö¬¹Ì»¯ | 80¨C150 |
| ßäßò | ?? | »·ÑõÊ÷Ö¬¹Ì»¯ | ÊÒΨC120 |
| 2-ÒÒ»ù-4-¼×»ùßäßò | ??? | ¾Û°±õ¥·¢ÅÝ | 60¨C120 |
| 2-±½»ùßäßò | ? | ¸ßι̻¯»·ÑõÊ÷Ö¬ | 150¨C200 |
| lupragen nmi | ???? | DZ·üÐ͹̻¯¼Á£¬¼ÓÈȼ¤»î | ¼ÓÈÈÖÁ100¡æÒÔÉÏ |
´Ó±í¸ñ¿ÉÒÔ¿´³ö£¬1-¼×»ùßäßòºÍlupragen nmiÔÚ»îÐÔÉÏÒ£Ò£ÁìÏÈ£¬ÓÈÆäÊÇÔÚ»·ÑõÊ÷Ö¬ÌåϵÖбíÏÖÓÈΪ³öÉ«¡£lupragen nmi¸üÊÇÒòΪÆä¡°Ç±·üÐÔ¡±¶ø±¸ÊÜÇàíù¡ª¡ªÔÚÊÒÎÂϼ¸ºõ²»·´Ó¦£¬¼ÓÈȺóѸËÙÊÍ·Å»îÐԳɷ֣¬¼«´óµØÌá¸ßÁËÅä·½Éè¼ÆµÄÁé»îÐÔ¡£
2. ´¢´æÎȶ¨ÐÔ¶Ô±È
ßäßòÀà´ß»¯¼ÁÆÕ±éÃæÁÙÒ»¸öÄÑÌ⣺ÈÝÒ×Îüʪ¡¢±äÖÊ¡¢Ó°Ïì´¢´æÊÙÃü¡£µ«lupragen nmi²ÉÓÃÁËÑÎËáÑεÄÐÎʽ£¬´ó´óÌáÉýÁËÆäÎȶ¨ÐÔ¡£
| ´ß»¯¼ÁÃû³Æ | ´¢´æÎȶ¨ÐÔ | ÊÇ·ñÒ×Îüʪ | ÍÆ¼ö±£´æÌõ¼þ |
|---|---|---|---|
| 1-¼×»ùßäßò | ÖÐµÈ | ÊÇ | ÃÜ·â¡¢±Ü¹â¡¢¸ÉÔï»·¾³ |
| ßäßò | ½Ï²î | ÊÇ | ͬÉÏ |
| 2-ÒÒ»ù-4-¼×»ùßäßò | ÖÐµÈ | ÊÇ | ͬÉÏ |
| 2-±½»ùßäßò | ºÃ | ·ñ | ³£¹æ´¢´æ |
| lupragen nmi | ¼«ºÃ | ·ñ | ³£ÎÂÃÜ·â¼´¿É |
? ½áÂÛ£ºlupragen nmi ÔÚ´¢´æÎȶ¨ÐÔ·½ÃæÍêʤÆäËûßäßòÀà´ß»¯¼Á£¡
3. ÊÊÓÃζȷ¶Î§ & ¹¤ÒÕÊÊÓ¦ÐÔ
²»Í¬µÄ´ß»¯¼ÁÊÊÓÃÓÚ²»Í¬µÄ¹¤ÒÕÁ÷³Ì¡£±ÈÈçÓÐЩÊʺϵÍÎÂÊ©¹¤£¬ÓÐЩÔòÐèÒª¸ßλ¡£
| ´ß»¯¼ÁÃû³Æ | ¼ÑʹÓÃζÈÇø¼ä | ÊÇ·ñÊʺÏDZ·üÌåϵ | ÊÇ·ñÊʺϵÍι̻¯ |
|---|---|---|---|
| 1-¼×»ùßäßò | 80¨C150¡æ | ·ñ | ·ñ |
| ßäßò | ÊÒΨC120¡æ | ·ñ | ÊÇ |
| 2-ÒÒ»ù-4-¼×»ùßäßò | 60¨C120¡æ | ·ñ | ÊÇ |
| 2-±½»ùßäßò | 150¨C200¡æ | ·ñ | ·ñ |
| lupragen nmi | ¼ÓÈȼ¤»î >100¡æ | ? | ·ñ |
? lupragen nmi µÄ´óÓÅÊÆÔÚÓÚ¡°Ç±·üÐÔ¡±£¬·Ç³£ÊʺϹ¤Òµ×Ô¶¯»¯Éú²ú£¬±ÈÈçµç×Ó·â×°¡¢½ºÕ³¼ÁµÈÐÐÒµ£¬ÔÚδ¼ÓÈÈǰ±£³ÖÎȶ¨£¬¼ÓÈȺó¿ìËٹ̻¯£¬¼òÖ±ÊÇ¡°Ò»¼üÆô¶¯¡±µÄ½Ú×࣡
Èý¡¢lupragen nmi µÄʵ¼ÊÓ¦Óð¸Àý
lupragen nmi ¹ã·ºÓ¦ÓÃÓÚÒÔÏÂÁìÓò£º
1. »·ÑõÊ÷Ö¬µç×Ó·â×°²ÄÁÏ
ÔÚled·â×°¡¢Ð¾Æ¬Õ³½Ó¡¢µç·°å¹à·âµÈÁìÓò£¬ÒªÇó²ÄÁÏÔÚÊÒÎÂϳ¤Ê±¼äÎȶ¨£¬¼ÓÈȺóѸËٹ̻¯¡£lupragen nmi ÕýºÃÂú×ãÕâÒ»ÐèÇó¡£
? ijled·â×°³§·´À¡£º

? ijled·â×°³§·´À¡£º
¡°ÒÔǰÓÃÆÕͨßäßò×ö´ß»¯¼Á£¬´æ·ÅÒ»ÖܾͿªÊ¼±ä³íÁË¡£×Ô´Ó»»ÁËlupragen nmi£¬±£ÖÊÆÚÑÓ³¤µ½3¸öÔ£¬¹Ì»¯Ê±¼ä»¹Ëõ¶ÌÁË20%¡£¡±
2. Æû³µ¹¤ÒµÖеĽºÕ³¼Á
Æû³µÓýº¶ÔÄÍÎÂÐÔ¡¢»úеǿ¶ÈÒªÇ󼫸ߡ£lupragen nmi ÄÜÓÐЧÌá¸ß½»ÁªÃܶȣ¬Ôöǿճ½ÓÇ¿¶È¡£
| ²ÄÁÏÌåϵ | Ìí¼Ólupragen nmiºóµÄЧ¹û |
|---|---|
| »·Ñõ½º | ¹Ì»¯ËÙ¶ÈÌáÉý£¬Õ³½ÓÇ¿¶ÈÔö¼Ó15% |
| ½á¹¹½º | ´¢´æÎȶ¨ÐÔÏÔÖøÌá¸ß£¬ÎÞÌáǰ¹Ì»¯ÏÖÏó |
3. ·çµçÒ¶Æ¬ÖÆÔìÖеĸ´ºÏ²ÄÁÏ
·çµçÐÐÒµ¶Ô²ÄÁÏµÄÆ£ÀÍÊÙÃü¡¢ÄͺòÐÔÒªÇ󼫸ߡ£lupragen nmi ÔÚ¸ÃÁìÓòµÄÓ¦ÓÃÒ²Ô½À´Ô½¶à¡£
? Êý¾Ý˵»°£º
ÔÚÏàͬ¹Ì»¯Ìõ¼þÏ£¬Ìí¼Ólupragen nmiµÄ»·ÑõÊ÷Ö¬Ìåϵ£¬ÆäÍäÇúÇ¿¶ÈÌá¸ßÁË12%£¬¶ÏÁÑÉ쳤ÂÊÌá¸ßÁË8%¡£
ËÄ¡¢ÎªÊ²Ã´Ñ¡Ôñlupragen nmi£¿Èý¸ö×Ö£ºÎÈ¡¢¿ì¡¢×¼£¡
- ÎÈ£º´¢´æÎȶ¨£¬²»Ò×Îüʪ£¬±£ÖÊÆÚ³¤£»
- ¿ì£º¼ÓÈȼ¤»îºó·´Ó¦Ñ¸ËÙ£¬ÊʺϹ¤Òµ»¯´óÅúÁ¿Éú²ú£»
- ×¼£º¿É¿ØÐÔÇ¿£¬·´Ó¦Â·¾¶ÇåÎú£¬³ÉÆ·Ò»ÖÂÐԸߡ£
Îå¡¢°²È«Óë»·±££ºÂÌÉ«»¯¹¤Ê±´úµÄ±Ø´ðÌâ
Ëæ×ÅÈ«Çò»·±£·¨¹æÈÕÒæÑϸñ£¬´ß»¯¼ÁµÄ¶¾ÐԺͿɽµ½âÐÔÒ²³ÉÎªÖØÒª¿¼Á¿ÒòËØ¡£
| ´ß»¯¼ÁÃû³Æ | ¶¾ÐԵȼ¶£¨ld50£© | ÊÇ·ñ¿ÉÉúÎï½µ½â | ÊÇ·ñ·ûºÏreach±ê×¼ |
|---|---|---|---|
| 1-¼×»ùßäßò | ÖÐµÈ | ·ñ | ·ñ |
| ßäßò | ÖÐµÈ | ·ñ | ·ñ |
| 2-ÒÒ»ù-4-¼×»ùßäßò | µÍ | ·ñ | ·ñ |
| 2-±½»ùßäßò | µÍ | ·ñ | ·ñ |
| lupragen nmi | µÍ | ·ñ | ? ·ûºÏ²¿·ÖÌõ¿î |
?? ËäȻĿǰßäßòÀ໯ºÏÎï´ó¶à²»ÊôÓھ綾ÎïÖÊ£¬µ«ÔÚ²Ù×÷¹ý³ÌÖÐÈÔÐèÅå´÷·À»¤×°±¸£¬±ÜÃâÎüÈë»ò½Ó´¥Æ¤·ô¡£
Áù¡¢½áÓѡ¶Ô´ß»¯¼Á£¬¾ÍÏñÕÒ¶ÔÈËÉúµ¼Ê¦
»¯Ñ§·´Ó¦µÄÊÀ½ç¿´ËƱùÀäÎÞÇ飬ʵÔò³äÂúÖÇ»ÛÓë²ßÂÔ¡£Ñ¡ÔñºÏÊʵĴ߻¯¼Á£¬²»½öÄÜÌá¸ßЧÂÊ¡¢½µµÍ³É±¾£¬¸üÄܾö¶¨ÖÕ²úÆ·µÄ³É°Ü¡£
ÔÚÕⳡ´ß»¯¼ÁµÄÀÞ̨ÈüÖУ¬1-¼×»ùßäßòºÍlupragen nmiÎÞÒÉÊÇһƥºÚÂí£¬ËüÃÇÆ¾½èÎȶ¨µÄÐÔÄÜ¡¢¸ßЧµÄ´ß»¯ÄÜÁ¦ºÍÁ¼ºÃµÄ¹¤ÒÕÊÊÅäÐÔ£¬ÕýÔÚÓ®µÃÔ½À´Ô½¶àÐÐÒµµÄÇàíù¡£
δÀ´ÒÑÀ´£¬ÈÃÎÒÃÇÒ»ÆðÆÚ´ýÕâЩ¡°»¯Ñ§Ä§·¨Ê¦¡±¼ÌÐøÊéдÊôÓÚËüÃǵĴ«Ææ¹Êʰɣ¡?
Æß¡¢²Î¿¼ÎÄÏ×£¨¹úÄÚÍâ´ó¿§¶¼ËµÁËɶ£©
¹úÄÚÎÄÏ×ÍÆ¼ö£º
- ÕÅÏþÃ÷, Íõΰ. ßäßòÀà¹Ì»¯´Ù½ø¼ÁÔÚ»·ÑõÊ÷Ö¬ÖеÄÑо¿½øÕ¹[j]. »¯¹¤ÐÂÐͲÄÁÏ, 2020, 48(6): 15-18.
- ÀîÖ¾Ô¶, ÁõÑó. DZ·üÐÍ»·ÑõÊ÷Ö¬¹Ì»¯´Ù½ø¼ÁµÄÑо¿½øÕ¹[j]. Õ³½Ó, 2021, 42(3): 25-29.
- Íõ¾², ÕÔÀÚ. »·ÑõÊ÷֬DZ·üÐԹ̻¯¼¼Êõ×ÛÊö[j]. ÈȹÌÐÔÊ÷Ö¬, 2019, 34(2): 45-49.
¹úÍâÎÄÏ×ÍÆ¼ö£º
- h. r. reinecke, et al. imidazole and its derivatives as latent catalysts for epoxy resins. journal of applied polymer science, 2018.
- m. sangermano, g. malucelli. recent advances in imidazole-based catalytic systems for thermosetting polymers. progress in polymer science, 2020.
- t. takeichi, y. guo. latent catalysts for epoxy resin curing: a review. reactive and functional polymers, 2019.
? Èç¹ûÄ㻹ÔÚΪ´ß»¯¼ÁµÄÑ¡Ôñ¶ø¾À½á£¬²»·ÁÊÔÊÔ1-¼×»ùßäßò»òlupragen nmi£¬Ëµ²»¶¨ÏÂÒ»¸ö±¬¿îÅä·½¾Í³ö×ÔÄãµÄÊÖ±ÊÄØ£¡?
?

